You just read:

Boehringer Ingelheim Welcomes Central Role of LABA/LAMA Therapy within 2017 GOLD Strategy for COPD

News provided by

Boehringer Ingelheim Pharmaceuticals

Nov 17, 2016, 08:00 ET